Live Breaking News & Updates on Enhancing Anti Viral
Stay updated with breaking news from Enhancing anti viral. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CALGARY, Alberta, Jan. 31, 2022 XORTX Therapeutics Inc. , a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, is pleased to. | January 31, 2022 ....
XORTX Files New Provisional Patent to Treat and Protect Individuals Most at Risk to Severe Viral Infection newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
XORTX Therapeutics Inc.: XORTX Files New Provisional Patent to Treat and Protect Individuals Most at Risk to Severe Viral Infection CALGARY, AB / ACCESSWIRE / March 8, 2021 / XORTX Therapeutics Inc. XORTX or the Company ) (CSE:XRX) (OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, with late-stage clinical programs, is pleased to announce the filing of a new provisional patent application entitled Compositions and Methods for Enhancing Anti-Viral Therapies . This provisional patent was filed with the US Patent Office on Friday, March 5, 2021. In addition, studies of Coronavirus infections show that SARS and MERS and specifically COVID-19 can be frequently accompanied by pneumonia, acute kidney injury, proteinuria and hematuria ....